Ethic Inc. Dexcom Inc Transaction History

Ethic Inc.

$3.97 Billion
Q3 2024

A detailed history of Ethic Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Ethic Inc. holds 36,035 shares of DXCM stock, worth $2.88 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

36,035

Previous 37,810 4.69%

Holding current value

$2.88 Million

Previous $4.29 Million 43.65%

% of portfolio

0.06%

Previous 0.1%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$64.0 - $116.06 $113,600 - $206,006	-1,775 Reduced 4.69%	36,035 $2.42 Million
Q2 2024 Aug 13, 2024	BUY	$110.31 - $140.45 $195,800 - $249,298	1,775 Added 4.93%	37,810 $4.29 Million
Q1 2024 May 13, 2024	BUY	$114.22 - $140.1 $344,601 - $422,681	3,017 Added 9.14%	36,035 $5 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $152,942 - $251,548	2,026 Added 6.54%	33,018 $4.1 Million
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $135,974 - $217,929	-1,580 Reduced 4.85%	30,992 $2.89 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $536,032 - $624,250	4,766 Added 17.14%	32,572 $4.19 Million
Q1 2023 May 12, 2023	BUY	$104.0 - $122.92 $159,536 - $188,559	1,534 Added 5.84%	27,806 $3.23 Million
Q4 2022 Feb 14, 2023	SELL	$84.98 - $122.67 $142,086 - $205,104	-1,672 Reduced 5.98%	26,272 $2.98 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $240,884 - $297,137	3,155 Added 12.73%	27,944 $2.25 Million
Q2 2022 Aug 10, 2022	BUY	$67.99 - $132.89 $1.31 Million - $2.56 Million	19,272 Added 349.32%	24,789 $1.85 Million
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $157,584 - $218,084	1,675 Added 43.6%	5,517 $2.82 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $358,311 - $449,220	2,759 Added 254.76%	3,842 $2.06 Million
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $115,566 - $155,063	1,083 New	1,083 $592,000

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.

Account